Literature DB >> 35305031

Covid-19 and Covid-19 vaccine can slide along sides: a report of two cases of unilateral periflexural exanthema.

A Sechi1,2, A Bassi3, C Mazzatenta3, M Cutrone4, L Naldi1, G Argenziano5, V Piccolo5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35305031      PMCID: PMC9114993          DOI: 10.1111/jdv.18093

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   9.228


× No keyword cloud information.

Conflict of interest

None declared. Dear Editor, We herein report two cases of unilateral peripheral rash occurring in a paediatric patient and a young adult, respectively, during SARS‐CoV‐2 infection and after Covid‐vaccine administration. Case 1: a healthy 24‐year‐old woman presented an unilateral maculopapular eruption arising from her left groin, spreading up the side to involve the trunk and the left armpit, and to a lesser extent, contralateral groin (Fig. 1). The rash was moderately itchy and consisted of discrete 1–4 mm‐sized macules and papules with a tendency to coalescence in patchy erythema. Acral sites and mucous membranes were spared. The patient's past history was unremarkable, but she had received the second dose of Comirnaty® in the 48 h preceding the onset of the rash. Notably, the patient had never contracted the Sars‐Cov2 infection, and her serological tests and swab test performed shortly before the first dose were negative. No other triggers could be identified, as the patient did neither complain of any systemic symptoms nor had taken any drugs or applied any products in the preceding three weeks. Laboratory screenings for blood count, autoimmunity, renal and hepatic functions were within normal ranges, whereas a mild raise of C‐reactive protein was found (5.2 mg/dL). The patient was dismissed with the prescription of topical mometasone 1%, and the rash eventually resolved 3 weeks after. Case 2: a 1‐year‐old female child, isolated with her family due to a positive nasopharyngeal swab for Sars‐Cov2, sought our teleconsultation for a unilateral maculopapular rash that appeared a couple of days before. Cutaneous lesions were asymptomatic and exclusively affected the right side of the body, mostly at the trunk and limbs (Fig. 2). Systemic symptoms were mild and included flu‐like symptoms, namely cough and cold. Currently, the rash is still present after 10 days, but is progressively fading with time. Since the advent of the pandemic, multiple skin manifestations have been reported in association with SARS‐CoV‐2 infection or as immune‐mediated events triggered by the administration of Covid‐vaccines. , However, only a few reports of predominant unilateral rash have been linked to Covid‐19. These include a case of asymmetrical periflexural rash arising with a marked predominance of the right side in a 42‐year‐old woman affected by Covid‐19, and a purpuric rash involving unilaterally the left inguinal region of a 58‐year‐old man, hospitalized for Covid‐19, which mainly ran asymptomatic, but caused ground glass pulmonary changes on the CT‐scan. Unilaterality was also reported as a distinctive feature in one case of leukocytoclastic vasculitis of the lower limbs, which occurred 4 days after the second dose of COVAXIN® administered to a 31‐year‐old woman, unaffected by previous medical conditions. Few exanthems are characterized by a distinct one‐side predominance, including asymmetric periflexural exanthem of childhood (APEC), unilateral laterothoracic exanthem, and its variant known as unilateral mediothoracic exanthem. The terms often design the same affection, although APEC is extremely rare in adults, being predominant among 1‐ to 5‐year‐old children; also it recognizes a viral aetiology in most cases, and usually peaks in the winter and springtime. The reason for the unilateral predilection is still unexplained, although a post‐zygotic mutation that makes one‐sided keratinocytes more susceptible to infectious triggers has been postulated. It is possible that in our cases the keratinocytes of one side show, for the same reason, different reactogenicity to potential triggers. The production of the spike protein is a key element to elicit immune‐driven skin reactions, mainly because it shares genetic analogies to human endogenous cross‐reactive antigens. As a consequence, both Sars‐CoV‐2 infection and Covid‐vaccine, which are based on spike protein sequences, could trigger similar effects in genetically predisposed individuals. Besides molecular mimicry, other mechanisms may be implied, including T‐cell mediate immune reactions, superantigen spreading, generation of autoreactive lymphocytes and cross‐reactive antibodies with consequent release of pro‐inflammatory cytokines. ,
Figure 1

Mildly itchy macules and papules spread along the left lateral thoracic wall and, in a less predominant fashion, the contralateral groin.

Figure 2

Covid‐positive child with unilateral popular eruption located at his right side of the trunk and proximal lower limbs.

Mildly itchy macules and papules spread along the left lateral thoracic wall and, in a less predominant fashion, the contralateral groin. Covid‐positive child with unilateral popular eruption located at his right side of the trunk and proximal lower limbs.
  10 in total

1.  Superimposed lateralized exanthem of childhood: report of a case related to adenovirus infection.

Authors:  A Niedermeier; W Pfützner; T Ruzicka; P Thomas; R Happle
Journal:  Clin Exp Dermatol       Date:  2014-04       Impact factor: 3.470

Review 2.  Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects.

Authors:  Carlo Perricone; Serena Colafrancesco; Roei D Mazor; Alessandra Soriano; Nancy Agmon-Levin; Yehuda Shoenfeld
Journal:  J Autoimmun       Date:  2013-11-13       Impact factor: 7.094

3.  Unilateral mediothoracic exanthem: a variant of unilateral laterothoracic exanthem.

Authors:  Antonio A T Chuh; Henry H L Chan
Journal:  Cutis       Date:  2006-01

4.  BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2.

Authors:  V Piccolo; A Bassi; G Argenziano; C Mazzatenta; M Cutrone; I Neri; R Grimalt; T Russo
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-05-10       Impact factor: 9.228

5.  Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine.

Authors:  Darja Kanduc; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2020-09-18       Impact factor: 2.829

6.  Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID-19 vaccine.

Authors:  A Sechi; E Pierobon; E Pezzolo; L Germi; G Trevisan; D Zardo; G Riva; S Mondino; L Naldi
Journal:  Clin Exp Dermatol       Date:  2021-10-21       Impact factor: 4.481

7.  Unilateral laterothoracic exanthem in association with coronavirus disease 2019.

Authors:  Laura R Glick; Alexander L Fogel; Sarika Ramachandran; Lydia Aoun Barakat
Journal:  JAAD Case Rep       Date:  2020-07-21

8.  A unilateral purpuric rash in a patient with COVID-19 infection.

Authors:  Zeynep Karaca; Savaş Yayli; Okan Çalışkan
Journal:  Dermatol Ther       Date:  2020-07-08       Impact factor: 3.858

9.  Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients.

Authors:  V Piccolo; I Neri; C Filippeschi; T Oranges; G Argenziano; V C Battarra; S Berti; F Manunza; A B Fortina; V Di Lernia; V Boccaletti; G De Bernardis; B Brunetti; C Mazzatenta; A Bassi
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05-15       Impact factor: 6.166

10.  Asymmetrical cutaneous vasculitis following COVID-19 vaccination with unusual eosinophil preponderance.

Authors:  V Kharkar; T Vishwanath; S Mahajan; R Joshi; P Gole
Journal:  Clin Exp Dermatol       Date:  2021-07-29       Impact factor: 4.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.